If you had to choose one rule of thumb to sum up AI in healthcare, it might be, “The more data, the better.”
That’s largely because for AI to work effectively its algorithms need to be “trained” on as rich a supply of data points as possible in whatever field is the fundamental target for analysis.
To that end, Progknowse Inc., a precision medicine technology startup, has announced partnerships with three leading U.S. health systems with the goal of producing predictive analytics with state-of-the-art algorithms using machine learning.
The three health systems include LifeBridge Health in Baltimore, Maryland, Riverside Health System in Newport News, Virginia, and St. Luke’s University Health Network in Bethlehem, Pennsylvania.
According to a statement, Prognowse will leverage the PremierConnect platform to access national data sets, which include de-identified clinical outcomes data on approximately 45 percent of all U.S. patient discharges, that will then be used to help advance and personalize treatment based on clinical information, including the individual genetic information of specific patients.
Progknowse partners with health systems, such as its three new partners, that seek to share a computing architecture for predictive analytics associated with precision medicine. This includes giving access to anonymized clinical and administrative data to data scientists to build predictive algorithms that accurately measure and predict patient outcomes based on thousands of individual predictors.
“When we started Progknowse, our mission was to use precision medicine to improve patient outcomes,” said Marshall Ruffin, MD, Progknowse’s Founder and CEO. “Our partnership with Premier and these exemplary health systems enables clinician-driven data science collaboration that helps solve the problems of predictive accuracy and risk-adjustment crucial to improving the way care is delivered in precise and personalized ways.”
"These kinds of innovations and strategic partnerships enable us to enhance care for the patients and communities we serve," said Daniel J. Durand, chief innovation officer and vice president of research at LifeBridge Health.
By collaborating with Progknowse, Durand explained, LifeBridge would have access to advanced capabilities such as predictive analytics and artificial intelligence that will “in turn help ensure all patients receive care that is uniquely tailored to their biology, personal needs and preferences.”
Together with Premier Inc., the healthcare improvement company that is providing the data, Progknowse is working with providers to develop and operationalize predictive algorithms for precise, actionable therapeutic recommendations to improve and personalize care delivery.